OUR
MISSION
OUR
MISSION
→ Around 300,000 Europeans are living with muscular diseases.
→ At least 10,000 individuals in Europe are affected by spinal cord injuries (paralysis) each year.
→ 1 in 5 workers experiences muscular pain in the upper limbs.
Lack of access to assistive technology worsens social exclusion, increases precariousness, reduces autonomy, and accelerates disease progression.
→ Around 300,000 Europeans are living with muscular diseases.
→ At least 10,000 individuals in Europe are affected by spinal cord injuries (paralysis) each year.
→ 1 in 5 workers experiences muscular pain in the upper limbs.
Lack of access to assistive technology worsens social exclusion, increases precariousness, reduces autonomy, and accelerates disease progression.
OUR SOCIAL COMMITMENT
OUR SOCIAL COMMITMENT
ORTHOPUS’ approach and strategy are based on the United Nations Sustainable Development Goals (SDGs) to address global challenges, as well as the recommendations from the WHO’s health and disability reports. We utilize WHO guidelines to guide our efforts toward accessibility and to take action in areas such as policy, products, health professionals, provision, and users.
KEY RESOURCES ON GLOBAL DISABILITY ISSUES:
ORTHOPUS’ approach and strategy are based on the United Nations Sustainable Development Goals (SDGs) to address global challenges, as well as the recommendations from the WHO’s health and disability reports. We utilize WHO guidelines to guide our efforts toward accessibility and to take action in areas such as policy, products, health professionals, provision, and users.
KEY RESOURCES ON GLOBAL DISABILITY ISSUES:
The Sustainable Development Goals we are committed to:
The Sustainable Development Goals we are committed to:
AT ORTHOPUS, WE ARE COMMITTED TO
AT ORTHOPUS, WE ARE COMMITTED TO
Co-designing user-centered medical devices.
We actively incorporate feedback from users, their caregivers, and health professionals at every stage of development, including the formulation of technical specifications, prototype testing, beta testing, and feedback during daily use.
Co-designing user-centered medical devices.
We actively incorporate feedback from users, their caregivers, and health professionals at every stage of development, including the formulation of technical specifications, prototype testing, beta testing, and feedback during daily use.
The accessibility of assistive devices (including fair pricing, usability, and acceptability).
As a specific engagement, we implement moderate margins to ensure our robotic solutions are more affordable than comparable products available in the market.
The accessibility of assistive devices (including fair pricing, usability, and acceptability).
As a specific engagement, we implement moderate margins to ensure our robotic solutions are more affordable than comparable products available in the market.
Sharing knowledge to effect change in the medical field.
We prioritize open communication by sharing as much information as possible, including key insights into the assistive technology landscape, pricing strategies, other available devices on the market, and financial support options. Our goal is to empower users and their families to take an active role in the fitting process and simplify their experience.
Sharing knowledge to effect change in the medical field.
We prioritize open communication by sharing as much information as possible, including key insights into the assistive technology landscape, pricing strategies, other available devices on the market, and financial support options. Our goal is to empower users and their families to take an active role in the fitting process and simplify their experience.
Since 2019, ORTHOPUS officially holds ESUS approval for its mission and social commitment as a social impact company. This French designation is granted based on specific criteria, including the social utility of the project, democratic governance involving the company’s stakeholders, a controlled remuneration policy, and the reinvestment of the majority of profits into the company’s operations to fulfill its social mission.
If you want to know more about our commitment, you can read our article here.
Since 2019, ORTHOPUS officially holds ESUS approval for its mission and social commitment as a social impact company. This French designation is granted based on specific criteria, including the social utility of the project, democratic governance involving the company’s stakeholders, a controlled remuneration policy, and the reinvestment of the majority of profits into the company’s operations to fulfill its social mission.
If you want to know more about our commitment, you can read our article here.